# EDGAR Filing Document

**Accession Number:** 0001844392
**File Stem:** 0001213900-26-050958
**Filing Date:** 2026-5
**Character Count:** 9773
**Document Hash:** e17228be806983d137a96ca76c32c2d2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-050958.hdr.sgml**: 20260501

**ACCESSION NUMBER**: 0001213900-26-050958

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20260429

**ITEM INFORMATION**: Entry into a Material Definitive Agreement

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20260501

**DATE AS OF CHANGE**: 20260501

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Marpai, Inc.
- **CENTRAL INDEX KEY:** 0001844392
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40904
- **FILM NUMBER:** 26932741

**BUSINESS ADDRESS:**
- **STREET 1:** 615 CHANNELSIDE DRIVE
- **STREET 2:** SUITE 207
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602
- **BUSINESS PHONE:** 646-303-3483

**MAIL ADDRESS:**
- **STREET 1:** 615 CHANNELSIDE DRIVE
- **STREET 2:** SUITE 207
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33602

?xml version='1.0' encoding='ASCII'?

**UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934**

**Date of Report (Date of earliest event reported): April 29, 2026**

**MARPAI, INC.**

**(Exact name of Registrant as Specified in Its Charter)**

---

| | | |
|:---|:---|:---|
| **Delaware** | **001-40904** | **86-1916231** |
| **(State or Other Jurisdiction<br> of Incorporation)** | **(Commission File Number)** | **(IRS Employer<br> Identification No.)** |

---

---

| | |
|:---|:---|
| **615 Channelside Drive, Suite 207**<br>**Tampa, Florida** | **33602** |
| **(Address of Principal Executive Offices)** | **(Zip Code)** |

---

**Registrant's Telephone Number, Including Area Code: (855) 389-7330**

**(Former Name or Former Address, if Changed Since Last Report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange on which registered** |
| Class A Common Stock, par value $0.0001 per share | MRAI | OTCQX Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry into a Material Definitive Agreement.**

As previously disclosed, on February 13, 2026, Marpai, Inc. (the "<u>Company</u>") issued a promissory note (the "<u>Note</u>") in the principal amount of $410,000 to Damien Lamendola, the Company's Chief Executive Officer (the "<u>Holder</u>"), with an interest rate of 12% per annum and that matures on April 11, 2026.

In addition, and as previously disclosed, on March 9, 2026, the Company issued a second promissory note (the "<u>Second Note</u>") in the principal amount of $250,000 to the Holder with an interest rate of 12% per annum and that matures on May 10, 2026.

On April 29, 2026, the Company entered into an Amendment Agreement (the "<u>Amendment Agreement</u>") with the Holder pursuant to which the maturity date of the Note and the Second Note for the outstanding principal and interest was extended from April 11, 2026 and May 10, 2026, respectively, to September 1, 2026. All other terms and conditions of the Note and the Second Note remain unchanged.

The foregoing does not purport to be a complete description of the Amendment Agreement, and such description is qualified in its entirety by reference to the full text of such document, which is attached as Exhibit 10.1 to this Current Report on Form 8-K (this "<u>Form 8-K</u>") and is incorporated by reference herein.

**Item 9.01 Financial Statements and Exhibits.**

(d) Exhibits

---

| | |
|:---|:---|
| **Exhibit<br> Number** | **Description** |
| 10.1 | [Form of Promissory Note Amendment Agreement, dated as of April 29, 2026, between the Company and Damien Lamendola.](ea028866501ex10-1.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | MARPAI, INC. | MARPAI, INC. | MARPAI, INC. |
| Date: May 1, 2026 | By: | /s/ Damien Lamendola | /s/ Damien Lamendola |
|  |  | Name: | Damien Lamendola |
|  |  | Title: | Chief Executive Officer |

---

## Exhibit 10.1

**Exhibit 10.1**

**AMENDMENT TO PROMISSORY NOTES**

This Amendment (this "***Amendment***"), dated as of April 29, 2026, to those certain Promissory Notes, issued by Marpai Inc. (the "***Borrower***") to Damien Lamendola (the "***Holder***") on each of February 12, 2026 and March 9, 2026 (the "***Notes***") is made and entered into by and between the Borrower and the Holder. Capitalized terms used but not defined herein shall have the meaning ascribed to them in the Notes, as applicable.

**WHEREAS**, the Notes were issued by the Borrower on February 12, 2026 and March 9, 2026, respectively, and such Notes may be amended only with the written consent of the Borrower and the Holder; and

**WHEREAS**, the Borrower and the Holder desire to amend the Note on the terms and conditions set forth below.

**NOW, THEREFORE**, in consideration of the mutual agreements contained herein, intending to be legally bound hereby, the parties agree as follows:

Section 1. <u>Amendments to Notes</u>. Section 1 of each of the Notes is hereby amended and restated in its entirety as follows:

"<u>Maturity</u>. On September 1, 2026 (the "**Stated Maturity Date**"), all of the obligations of the Borrower to the Lender, including all outstanding principal, interest and all other amounts due under this Note, shall be due and payable in full."

Section 2. <u>Remainder of Notes</u>. Except as set forth herein, the Notes are ratified and confirmed in all respects and shall not be amended or otherwise modified. All other terms and conditions of the Notes not in conflict with the terms of this Amendment shall remain in full force and effect. The execution, delivery and effectiveness of this Amendment shall not, except as expressly provided herein, (A) waive or modify any right, power or remedy under, or any other provision of, the Note or (B) commit or otherwise obligate the <u>Holder</u> to enter into or consider entering into any other amendment, waiver or modification of the Notes.

Section 3. <u>Governing Law</u>. This Amendment shall be governed by and construed under the internal laws of the State of New York as applied to agreements entered into and to be performed entirely within the State of New York. This Amendment (i) is for the exclusive benefit of the parties hereto and, together with the Note, constitutes the entire agreement of such parties, superseding all prior agreements among them, with respect to the subject matter hereof, (ii) may be modified, waived or assigned only in writing and only to the extent such modification, waiver or assignment would be permitted under the Note (and any attempt to assign this amendment without such writing shall be null and void). The fact that any term or provision of this amendment is held invalid, illegal or unenforceable as to any person in any situation in any jurisdiction shall not affect the validity, enforceability or legality of the remaining terms or provisions hereof or the validity, enforceability or legality of such offending term or provision in any other situation or jurisdiction or as applied to any person.

Section 4. <u>Entire Agreement and Amendments</u>. The Notes, as amended by this Amendment, embodies the entire agreement and understanding of the parties with respect to the subject matter hereof and supersede all prior agreements and understandings between the parties.

Section 5. <u>Counterparts</u>. This Amendment (or the signature pages hereof) may be executed in any number of counterparts; all such counterparts shall be deemed to constitute one and the same instrument; and each of said counterparts shall be deemed an original hereof.

[*remainder of page intentionally left blank; signature page follows*]

 

**IN WITNESS WHEREOF**, the parties hereto have caused this Amendment to be executed and delivered as of the date first above written.

---

| | |
|:---|:---|
| **BORROWER:** | **BORROWER:** |
| **Marpai Inc.** | **Marpai Inc.** |
| By: |  |
| Name: | Steve Johnson |
| Title: | Chief Financial Officer |
| **HOLDER:** | **HOLDER:** |
| By: |  |
| Name: | Damien Lamendola |

---